Evidence map›Paper›PMID 38231538›Full record

SynthesisJMIR mHealth and uHealth2024

Mobile Apps for COVID-19 Detection and Diagnosis for Future Pandemic Control: Multidimensional Systematic Review.

Mehdi Gheisari, Mustafa Ghaderzadeh, Huxiong Li, Tania Taami, Christian Fernández-Campusano, Hamidreza Sadeghsalehi, Aaqif Afzaal Abbasi

Erratum issuedOpen access · goldAbstract readSystematic Review
In one paragraph

Synthesis in JMIR mHealth and uHealth, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
8.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 36 citations in OpenAlex.

  1. The impact of artificial intelligence in the diagnosis and management of acoustic neuroma: A systematic review.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 6 countries.

Mehdi GheisariInstitute of Artificial Intelligence, Shaoxing University, Shaoxing, China.ORCID 0000-0002-5643-0021
Mustafa Ghaderzadeh *School of Nursing and Health Sciences of Boukan, Urmia University of Medical Sciences, Urmia, Iran.ORCID 0000-0003-4016-3843
Huxiong Li *Institute of Artificial Intelligence, Shaoxing University, Shaoxing, China.ORCID 0009-0004-6018-3141
Tania TaamiFlorida State University, Tallahassee, FL, United States.ORCID 0000-0002-9206-6183
Christian Fernández-CampusanoDepartamento de Ingeniería Eléctrica, Facultad de Ingeniería, Universidad de Santiago de Chile, Santiago, Chile.ORCID 0000-0001-7033-4178
Hamidreza SadeghsalehiDepartment of Neuroscience, Faculty of Advanced Technologies in Medicine, Tehran, Iran.ORCID 0000-0001-9783-7795
Aaqif Afzaal AbbasiDepartment of Earth and Marine Sciences, University of Palermo, Palermo, Italy.ORCID 0000-0002-9982-1321
Shaoxing University · CNFlorida State University · USUniversidad de Santiago de Chile · CLUniversity of Palermo · ITUrmia University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn the modern world, mobile apps are essential for human advancement, and pandemic control is no exception. The use of mobile apps and technology for the detection and diagnosis of COVID-19 has been the subject of numerous investigations, although no thorough analysis of COVID-19 pandemic prevention has been conducted using mobile apps, creating a gap.

objectiveWith the intention of helping software companies and clinical researchers, this study provides comprehensive information regarding the different fields in which mobile apps were used to diagnose COVID-19 during the pandemic.

methodsIn this systematic review, 535 studies were found after searching 5 major research databases (ScienceDirect, Scopus, PubMed, Web of Science, and IEEE). Of these, only 42 (7.9%) studies concerned with diagnosing and detecting COVID-19 were chosen after applying inclusion and exclusion criteria using the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) protocol.

resultsMobile apps were categorized into 6 areas based on the content of these 42 studies: contact tracing, data gathering, data visualization, artificial intelligence (AI)-based diagnosis, rule- and guideline-based diagnosis, and data transformation. Patients with COVID-19 were identified via mobile apps using a variety of clinical, geographic, demographic, radiological, serological, and laboratory data. Most studies concentrated on using AI methods to identify people who might have COVID-19. Additionally, symptoms, cough sounds, and radiological images were used more frequently compared to other data types. Deep learning techniques, such as convolutional neural networks, performed comparatively better in the processing of health care data than other types of AI techniques, which improved the diagnosis of COVID-19.

conclusionsMobile apps could soon play a significant role as a powerful tool for data collection, epidemic health data analysis, and the early identification of suspected cases. These technologies can work with the internet of things, cloud storage, 5th-generation technology, and cloud computing. Processing pipelines can be moved to mobile device processing cores using new deep learning methods, such as lightweight neural networks. In the event of future pandemics, mobile apps will play a critical role in rapid diagnosis using various image data and clinical symptoms. Consequently, the rapid diagnosis of these diseases can improve the management of their effects and obtain excellent results in treating patients.

Indexed as

COVID-19Mobile ApplicationsHumansPandemicsartificial intelligence: AIcloud computingCOVID-19detectiondiagnosisinternet of thingsmobile appmobile applicationsmobile appsmobile phonesmartphone

Identifiers

PMID38231538
PMCPMC10896318
OpenAlexW4385974372

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.